Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behazine Combadiere

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Frontiers in Immunology|November 27, 2020
Immune Profiles Identification by Vaccinomics After MVA Immunization in Randomized Clinical StudyJorge Sanchez, Elena Gonçalves, Anuska Llano, et al.
Human Gene Therapy|July 21, 2018
Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficency Virus Type 1 Clade C Envelope VaccineHannah Mary Cheeseman, Suzanne Day, Leon Robert McFarlane, et al.
Ebiomedicine|March 24, 2022
Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcomeBruna Oriol-Tordera, Anna Esteve-Codina, María Berdasco, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Frontiers in Immunology|November 27, 2020
Immune Profiles Identification by Vaccinomics After MVA Immunization in Randomized Clinical StudyJorge Sanchez, Elena Gonçalves, Anuska Llano, et al.
Human Gene Therapy|July 21, 2018
Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficency Virus Type 1 Clade C Envelope VaccineHannah Mary Cheeseman, Suzanne Day, Leon Robert McFarlane, et al.
Ebiomedicine|March 24, 2022
Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcomeBruna Oriol-Tordera, Anna Esteve-Codina, María Berdasco, et al.
Pageof 3